1257628-77-5 - Search Results | AbMole BioScience

Cat.No.	Name	Target
M6305	Olverembatinib	Src-bcr-Abl
	GZD824; HQP1351
	Olverembatinib is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.

Cat.No.

Name

Target

M6305

Olverembatinib

Src-bcr-Abl

GZD824; HQP1351

Olverembatinib is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.